- JP-listed companies
- CanBas Co.,Ltd.
- Financials
- Cash and cash equivalents
CanBas Co.,Ltd. (4575)
Market cap
¥13.6B
P/E ratio
Canvas is a biotech company that discovers and develops cancer drugs using its proprietary platform, from early research through clinical trials.
| Period End | Cash and cash equivalents (Million JPY) | YoY (%) |
|---|---|---|
| Jun 30, 2025 | 2,828 | +49.77% |
| Jun 30, 2024 | 1,888 | +16.71% |
| Jun 30, 2023 | 1,618 | +119.28% |
| Jun 30, 2022 | 738 | -36.11% |
| Jun 30, 2021 | 1,155 | +3.81% |
| Jun 30, 2020 | 1,112 | +45.66% |
| Jun 30, 2019 | 764 | +63.78% |
| Jun 30, 2018 | 466 | -47.57% |
| Jun 30, 2017 | 889 | +9.11% |
| Jun 30, 2016 | 815 | -7.93% |
| Jun 30, 2015 | 885 | +173.80% |
| Jun 30, 2014 | 323 |